Seeking Alpha

  Seattle Genetics, Inc. (SGEN) - NASDAQ

  • Richard Ryan | Send Message 7 Apr 2011

    SGEN linkers (ADC) may be the innovation that brings us one giant step closer to a cure for all cancers!
      SGEN vs. ETF Alternatives
      Company Description
      Seattle Genetics Inc is a biotechnology company. It develops and commercializes monoclonal antibody-based therapies for the treatment of cancer and autoimmune disease.
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States